Kate Mckinley - Net Worth and Insider Trading
Kate Mckinley Net Worth
The estimated net worth of Kate Mckinley is at least $23,528 dollars as of 2025-01-16. Kate Mckinley is the Chief Business Officer of Rani Therapeutics Holdings Inc and owns about 17,960 shares of Rani Therapeutics Holdings Inc (RANI) stock worth over $23,528. Details can be seen in Kate Mckinley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kate Mckinley has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kate Mckinley
Kate Mckinley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kate Mckinley owns 1 companies in total, including Rani Therapeutics Holdings Inc (RANI) .
Click here to see the complete history of Kate Mckinley’s form 4 insider trades.
Insider Ownership Summary of Kate Mckinley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RANI | Rani Therapeutics Holdings Inc | 2024-12-13 | CHIEF BUSINESS OFFICER |
Kate Mckinley Latest Holdings Summary
Kate Mckinley currently owns a total of 1 stock. Kate Mckinley owns 17,960 shares of Rani Therapeutics Holdings Inc (RANI) as of December 13, 2024, with a value of $23,528.
Latest Holdings of Kate Mckinley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RANI | Rani Therapeutics Holdings Inc | 2024-12-13 | 17,960 | 1.31 | 23,528 |
Holding Weightings of Kate Mckinley
Kate Mckinley Form 4 Trading Tracker
According to the SEC Form 4 filings, Kate Mckinley has made a total of 1 transactions in Rani Therapeutics Holdings Inc (RANI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rani Therapeutics Holdings Inc is the acquisition of 17,960 shares on December 13, 2024, which cost Kate Mckinley around $29,993.
Insider Trading History of Kate Mckinley
- 1
Kate Mckinley Trading Performance
GuruFocus tracks the stock performance after each of Kate Mckinley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kate Mckinley is %. GuruFocus also compares Kate Mckinley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kate Mckinley within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kate Mckinley's insider trading performs compared to the benchmark.
Performance of Kate Mckinley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -24.7 |  | | | | |
| Relative Return to S&P 500(%) | -21 | | | | | |
Kate Mckinley Ownership Network
Ownership Network List of Kate Mckinley
Ownership Network Relation of Kate Mckinley
Kate Mckinley Owned Company Details
What does Rani Therapeutics Holdings Inc do?
Who are the key executives at Rani Therapeutics Holdings Inc?
Kate Mckinley is the CHIEF BUSINESS OFFICER of Rani Therapeutics Holdings Inc. Other key executives at Rani Therapeutics Holdings Inc include director & CEO Talat Imran , 10 percent owner South Cone Investments Limited Partnership , and 10 percent owner Quiroga Cortes Isidoro Alfonso .
Rani Therapeutics Holdings Inc (RANI) Insider Trades Summary
Over the past 18 months, Kate Mckinley made 1 insider transaction in Rani Therapeutics Holdings Inc (RANI) with a net purchase of 17,960. Other recent insider transactions involving Rani Therapeutics Holdings Inc (RANI) include a net purchase of 50,296 shares made by Talat Imran , a net purchase of 1,435,805 shares made by South Cone Investments Limited Partnership , and a net sale of 5,265,165 shares made by Quiroga Cortes Isidoro Alfonso .
In summary, during the past 3 months, insiders sold 0 shares of Rani Therapeutics Holdings Inc (RANI) in total and bought 28,256 shares, with a net purchase of 28,256 shares. During the past 18 months, 9,094,525 shares of Rani Therapeutics Holdings Inc (RANI) were sold and 5,384,421 shares were bought by its insiders, resulting in a net sale of 3,710,104 shares.
Rani Therapeutics Holdings Inc (RANI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rani Therapeutics Holdings Inc Insider Transactions
Kate Mckinley Mailing Address
Above is the net worth, insider trading, and ownership report for Kate Mckinley. You might contact Kate Mckinley via mailing address: C/o Rani Therapeutics Holdings, Inc., 2051 Ringwood Ave., San Jose Ca 95131.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
